{"id":114659,"date":"2026-10-19T05:13:07","date_gmt":"2026-10-19T05:13:07","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/"},"modified":"2026-10-19T05:13:07","modified_gmt":"2026-10-19T05:13:07","slug":"nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/","title":{"rendered":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<ul>\n<li style=\"margin-top:0in; margin-bottom:0in; text-align:justify;\">Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. <\/li>\n<li style=\"margin-top:0in; margin-bottom:0in; text-align:left;\">Partnership leverages NorthStar&#8217;s vertically integrated campus, combining proprietary <br \/>Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure.<\/li>\n<\/ul>\n<p align=\"left\"><b>Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026<\/b> \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Nq4wWRD1C2xCPPDMuwzHfM22oVrHm9XdFUaJ4GUXc1HkuBpP_85bL-_rTPdSnkMWs6sj1r-UxY_aq0v0sPvdFw==\" rel=\"nofollow\" target=\"_blank\" title=\"NUCLIDIUM AG\">NUCLIDIUM AG<\/a>, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical supply-chain partner, today announced a long-term strategic partnership through which NorthStar will produce Copper-67 (Cu-67) and provide comprehensive radiopharmaceutical manufacturing services to support NUCLIDIUM&#8217;s therapeutic programs from clinical development through commercialization. Copper-67 is the therapeutic isotope component of NUCLIDIUM\u2019s radiotheranostic programs to treat cancers with high unmet medical need.<\/p>\n<p>The partnership underscores NUCLIDIUM and NorthStar\u2019s mutual commitment to expanding global patient access to precision radiopharmaceutical therapies. NUCLIDIUM\u2019s pipeline includes lead programs NU101 addressing metastatic castration resistant prostate cancer (mCRPC) and NU201 for metastatic breast cancer (mBC) as well as earlier stage programs in other solid tumor indications with a focus on women\u2019s oncology.<\/p>\n<p>The work will be led through NorthStar&#8217;s vertically integrated U.S.-based radiopharmaceutical campus, where the company has pioneered advanced isotope production technologies, made significant investments in cGMP manufacturing, and maintains commercial-scale infrastructure to support growing global demand for targeted radiopharmaceutical therapies. NorthStar\u2019s comprehensive approach enables a seamless transition from clinical development to commercialization, while reducing supply-chain complexity and accelerating program execution.<\/p>\n<p><em>\u201cOur collaboration with NorthStar strengthens our copper isotope supply chain at a critical moment, ensuring we are well prepared to execute on our near-term clinical development objectives and meet the long-term demand for our radiotheranostics,\u201d<\/em> said <strong>Leila Jaafar, PhD, CEO and Co-Founder of NUCLIDIUM<\/strong>. <em>\u201cNUCLIDIUM remains on track to initiate multiple therapeutic studies utilizing Copper-67 for mCRPC and mBC in the coming months, while expanding our radiotheranostic portfolio into the clinic, including specifically women\u00b4s oncology indications.\u201d<\/em><\/p>\n<p><em>\u201cAs demand for copper-based radiotheranostics continues to grow, reliable isotope supply and scalable manufacturing infrastructure will be essential for successful commercialization,\u201d <\/em>said <strong>Dr. Frank Scholz, President &amp; CEO of NorthStar<\/strong>. <em>\u201cNorthStar\u2019s integrated platform is designed to provide both, allowing NUCLIDIUM to advance its programs efficiently from clinical development through future commercial launch.\u201d<\/em><\/p>\n<p>Copper-67 is a short-range radioisotope that emits beta radiation to induce cell death in targeted tumor cells. The short half-life and lower radiation burden of Copper-67 limit the impact on surrounding healthy tissue. NUCLIDIUM\u2019s radiopharmaceutical programs link Copper-67 to tumor-specific ligands to enable precision delivery and have the potential to achieve a best- or first-in-class clinical profile. The use of copper isotopes offers several distinct advantages over competing radioligands, including streamlined manufacturing, seamless integration into hospital workflows, reduced waste burden, and the potential for a wider therapeutic window.<\/p>\n<p><b>About NUCLIDIUM<\/b><br \/>NUCLIDIUM AG is pioneering next-generation copper-based radiotheranostics that enable the direct conversion from cancer diagnosis to treatment. Leveraging copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, NUCLIDIUM has built a pipeline of differentiated candidates combining superior clinical performance, easy-to-scale production, and seamless integration into hospital workflows. The company\u2019s lead programs NU101 in metastatic castration-resistant prostate cancer (mCRPC) and NU201 in metastatic breast cancer (mBC) have demonstrated compelling efficacy and safety in Phase 1\/2 diagnostics trials and are advancing into Phase 1\/2 theranostics trials. Our goal is to expand the reach and clinical profile of radiotheranostics to deliver the full value of the modality and address critical unmet medical needs in oncology and women\u2019s health.<\/p>\n<p><b>About NorthStar<\/b><br \/>NorthStar is building the supply chain that powers the future of radiopharmaceutical medicine. Through its vertically integrated campus in Beloit, Wisconsin, NorthStar produces Copper-67 (Cu-67) and is the industry\u2019s first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron accelerator technology. The company combines isotope production, cGMP radiopharmaceutical manufacturing, and CDMO services in a single infrastructure platform designed to accelerate the development, commercialization, and delivery of life-changing cancer therapies to cancer patients worldwide.<\/p>\n<p align=\"left\"><strong>For more information, please contact:<\/strong><\/p>\n<p align=\"left\"><b>For NUCLIDIUM:<br \/><\/b>Leila Jaafar, PhD, CEO<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wOsE0BnKch1Q9lI3YYUNRDI_7Z00mBXNCMuR1AAG6nGyERNOvGfu1CoQ3ajSXGN12OUW04EJFX4rDoZjxE-9Jz-Fohj3rNov-3Hb7z0-03I=\" rel=\"nofollow\" target=\"_blank\" title=\"info@nuclidium.com\">info@nuclidium.com<\/a><\/p>\n<p><b>Investor\/Media Contact<br \/><\/b>Trophic Communications<br \/>Stephanie May<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HFrt32AZpHiezuT5uE9cuN6N6OFUtKZjIXp35Q3iELgGd9EPKVyONa8zPpUGxpUxlXHgcCnjbKGhiTg9nit4fqkPHokxgaU2eDd_64L5Kyo=\" rel=\"nofollow\" target=\"_blank\" title=\"nuclidium@trophic.eu\">nuclidium@trophic.eu<\/a><br \/>Phone: +49 171 1855682<\/p>\n<p><b>For NorthStar:<br \/><\/b>Eric Nelson<br \/>Communications Specialist<br \/>608-239-6812<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NqNvCJ3Q2tB8gOHFKw7TPJexu0R5b9lMk5Q6T9NThnNB3UFTAvw6NztrWXQrJE51HsD6FrHkyaFtPzrhVPgv-tYC_Z5yyvSu4QSonq7fmnGHB-bl00tY2Cqlv5MNZDmt\" rel=\"nofollow\" target=\"_blank\" title=\"enelson@northstarnm.com\">enelson@northstarnm.com<\/a><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=xncLZQuV7x98ETHhB7NEMYldY5XxYn0PADmTR-5NnJo3U2w-O0RYKkglGnvF8n9ZYH5vDokbRVpZZGtxYkQ3EinVq3DZmdw3-WHv5JUkDP5lcsY_ezl4eJtg6DZbr7Crs29sJglxAmFqN_eg1bdHtuoYWjSAjxgC-bxVoFMJe4cxNmBOkxbYOc0RE9NTFRZPPIeRxFiI-7xvzl3En5tKLSgSW8yeSHe5YqkZk2ChF0fpqIHgh-UYmBti5w8Azgwy5YThsd-fV5zWd5Fo25OnpcdOYiM7a95vlvxJ22B3RLQ0E-WXY5YgofHRlN_iI6zb\" title=\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline\" rel=\"nofollow\">NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline<\/a>\n      <\/li>\n<\/ul>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar&#8217;s vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":114660,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/1d4d34a4-57ec-416b-b58f-06af370ce718","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-114659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar&#039;s vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Gias Ul Hassan\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline\" \/>\n\t\t<meta property=\"og:description\" content=\"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar&#039;s vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-19T05:13:07+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-19T05:13:07+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar&#039;s vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#blogposting\",\"name\":\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\\u2019s Copper-67 Radiotheranostic Oncology Pipeline\",\"headline\":\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\\u2019s Copper-67 Radiotheranostic Oncology Pipeline\",\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/1d4d34a4-57ec-416b-b58f-06af370ce718\"},\"datePublished\":\"2026-10-19T05:13:07+00:00\",\"dateModified\":\"2026-10-19T05:13:07+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#webpage\"},\"articleSection\":\"GlobeNewswire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"position\":2,\"name\":\"GlobeNewswire\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#listItem\",\"name\":\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\\u2019s Copper-67 Radiotheranostic Oncology Pipeline\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#listItem\",\"position\":3,\"name\":\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\\u2019s Copper-67 Radiotheranostic Oncology Pipeline\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Pakistan-News.png\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#organizationLogo\",\"width\":191,\"height\":78,\"caption\":\"Pakistan-News\"},\"image\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/\",\"name\":\"Gias Ul Hassan\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#webpage\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/\",\"name\":\"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\\u2019s Copper-67 Radiotheranostic Oncology Pipeline\",\"description\":\"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar's vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \\\/ Munich, Germany, and Beloit, Wis. October 19, 2026 \\u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml-eu.globenewswire.com\\\/Resource\\\/Download\\\/1d4d34a4-57ec-416b-b58f-06af370ce718\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#mainImage\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\\\/#mainImage\"},\"datePublished\":\"2026-10-19T05:13:07+00:00\",\"dateModified\":\"2026-10-19T05:13:07+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","description":"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar's vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical","canonical_url":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#blogposting","name":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","headline":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/1d4d34a4-57ec-416b-b58f-06af370ce718"},"datePublished":"2026-10-19T05:13:07+00:00","dateModified":"2026-10-19T05:13:07+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#webpage"},"isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#webpage"},"articleSection":"GlobeNewswire"},{"@type":"BreadcrumbList","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#listItem","position":1,"name":"Home","item":"https:\/\/pakistaninewspaperlist.com\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","position":2,"name":"GlobeNewswire","item":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#listItem","name":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline"},"previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#listItem","position":3,"name":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}}]},{"@type":"Organization","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","url":"https:\/\/pakistaninewspaperlist.com\/news\/","logo":{"@type":"ImageObject","url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#organizationLogo","width":191,"height":78,"caption":"Pakistan-News"},"image":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author","url":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/","name":"Gias Ul Hassan"},{"@type":"WebPage","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#webpage","url":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/","name":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","description":"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar's vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website"},"breadcrumb":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#breadcrumblist"},"author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"creator":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/1d4d34a4-57ec-416b-b58f-06af370ce718","@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#mainImage"},"primaryImageOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/#mainImage"},"datePublished":"2026-10-19T05:13:07+00:00","dateModified":"2026-10-19T05:13:07+00:00"},{"@type":"WebSite","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website","url":"https:\/\/pakistaninewspaperlist.com\/news\/","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","inLanguage":"en-US","publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"}}]},"og:locale":"en_US","og:site_name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","og:type":"article","og:title":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","og:description":"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar's vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical","og:url":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/","og:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","og:image:secure_url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","article:published_time":"2026-10-19T05:13:07+00:00","article:modified_time":"2026-10-19T05:13:07+00:00","twitter:card":"summary_large_image","twitter:title":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","twitter:description":"Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through commercialization. Partnership leverages NorthStar's vertically integrated campus, combining proprietary Copper-67 production technology, cGMP manufacturing, and commercial-scale infrastructure. Basel, Switzerland \/ Munich, Germany, and Beloit, Wis. October 19, 2026 \u2013 NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical","twitter:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/\" title=\"GlobeNewswire\">GlobeNewswire<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/pakistaninewspaperlist.com\/news\/"},{"label":"GlobeNewswire","link":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/"},{"label":"NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM\u2019s Copper-67 Radiotheranostic Oncology Pipeline","link":"https:\/\/pakistaninewspaperlist.com\/news\/nuclidium-and-northstar-enter-long-term-strategic-partnership-to-advance-nuclidiums-copper-67-radiotheranostic-oncology-pipeline\/"}],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/114659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=114659"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/114659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/114660"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=114659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=114659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=114659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}